Jane Street’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Sell
27,600
-29,000
-51% -$222K ﹤0.01% 10018
2025
Q4
$550K Sell
56,600
-27,400
-33% -$233K ﹤0.01% 7459
2025
Q3
$352K Buy
84,000
+59,800
+247% +$382K ﹤0.01% 8603
2025
Q2
$225K Buy
+24,200
New +$211K ﹤0.01% 8357
2024
Q2
Sell
-10,700
Closed -$87.4K 10051
2024
Q1
$87.4K Sell
10,700
-11,600
-52% -$95.1K ﹤0.01% 8574
2023
Q4
$188K Buy
22,300
+1,900
+9% +$22K ﹤0.01% 8258
2023
Q3
$349K Buy
+20,400
New +$401K ﹤0.01% 6829

Other funds holding REPL

Jane Street's REPL Position: Q1 2026 in Review

Jane Street reduced its Replimune Group (REPL) stake by 27% in Q1 2026, selling an estimated $1.19M and leaving 428,145 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #4184.

Jane Street first reported a position in REPL in Q4 2022 and has held it in 13 quarters since. The position peaked at $5.68M in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Jane Street held 428,145 shares of Replimune Group worth $3.28M as of Q1 2026.
  • Jane Street sold 156,185 Replimune Group shares in Q1 2026, an estimated $1.19M.
  • Replimune Group made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4184 holding.
  • Jane Street first reported a position in Replimune Group in Q4 2022 and has held it in 13 quarters since.
  • Jane Street's Replimune Group position peaked at $5.68M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.